Диссертация (1146664), страница 23
Текст из файла (страница 23)
- 2014. - Vol. 9 (2). - P. 88934.228. Perez C., Fernandez-Galaz C., Fernandez-Agullo T. et al. Leptin impairsinsulin signaling in rat adipocytes // Diabetes. – 2004. – Vol. 53. – P. 347–353.229. Piya M. K., McTernan P.G., Kumar S. Adipokine inflammation and insulinresistance: the role of glucose, lipids and endotoxin // J. of endocrinology.
–2013. – Vol. 216. – Р. 1-15.230. Роеlhman E. T., Tchernof A. Transversing the menopause changes in energyexpenditure and body composition // Coronary Artery. Dis. – 1998. – Vol. 9. –P. 799–803.231. Pollare T., Lithell H., Berne C. Insuline resistance is a characteristic feature ofprimary hypertension independent of obesity // Metabolism. – 1990. –Vol. 39 (2). – P.
167–174.232. Porreca E., Di Febbo C., Fusco L., et al. Soluble thrombomodulin andvascular adhesion molecule-1 are associated to leptin plasma levels in obesewomen // Atherosclerosis. – 2004. – Vol. 172. – P. 175–180.233. Porter K. E., Turner N. A. Cardiac fibroblasts: at the heart of myocardialremodeling // Pharmacol. Ther. – 2009. – Vol.
123 (2). – P. 255–278.234. Reaven G. M., Lithell H., Landsberg L. Hypertension and associatedmetabolic abnormalities: the role of insulin resistance and the symphathoadrenal system // N. Engl. J. Med. – 1996. – Vol. 334. – P. 374–381.140235. Rendell M., Hulthem U. L., Tornquist C. et al.
Relationship betweenabdominal fat compartments and glucose and lipid metabolism in earlypostmenopausal women // J. Clin. Endocrinol. Metab. – 2001. – Vol. 86. –P. 744–749.236. Rigamonti A. E., Agosti F., De Col A. et al. Severely obese adolescents andadults exhibit a different association of circulating levels of adipokines andleukocyte expression of the related receptors with insulin resistance // Int.
J.Endocrinol. – 2013: 565967.237. Ridker P. M. Hightsensitivity C-reactive protein: potential adjunct for globalrisk assessment in the primary prevention of cardiovascular disease //Circulation. – 2001. – Vol. 103. – P. 1813–1818.238. Rodilla E., Costa J. A., Martín J. et al. Impact of abdominal obesity andambulatory blood pressure in the diagnosis of left ventricular hypertrophy innever treated hypertensives // Med. Clin. (Barc).
– 2013. – [Epub ahead ofprint].239. Rodriguez-Lee M., Bondjers G., Camejo, G. Fatty acid-induced atherogenicchanges in extracellular matrix proteoglycans // Curr. Opin. Lipidol. – 2007. –Vol. 18. – P. 546–553.240. Roh S. G., Song S. H., Choi K. C. et al. Chemerin – a new adipokine thatmodulates adipogenesis via its own receptor // Biochem. and Biophys. Res.Commun. – 2007.
– Vol. 362. – P. 1013–1018.241. Rosenson R. S., Gelb M. H. Secretory phospholipase A2: a multifacetedfamily of proatherogenic enzymes // Curr. Cardiol. Rep. – 2009. – Vol. 11. –P. 445–451.242. Samson M., Edinger A. L., Stordeur P. et al. ChemR23, a putativechemoattractant receptor, is expressed in monocyte-derived dendritic cells andmacrophages and is a coreceptor for SIV and some primary HIV-1 strains //Eur. J. Immunology. – 1998.
– Vol. 28. – P. 1689–1700.141243. Sato N., Kobayashi K., Inoguchi T. et al. Adenovirus-mediated highexpression of resistin causes dyslipidemia in mice // Endocrinology. – 2005. –Vol. 146. – P. 273–279.244. Satoh N., Ogawa Y, Katsuura G et al. Sympathetic activation of leptin via theventromedial hypothalamus: leptin-induced increase in catecholamine secretion// Diabetes. - 1999. - P. 1787-1793.245.
Schiffrin E. L. T lymphocytes: a role in hypertension // Curr. Opin. Nephrol.Hypertens. – 2010. – Vol. 19 (2). – P. 181–186.246. Schiffrin E. L. Immune modulation of resistance artery remodeling // BasicClin. Pharmacol. Toxicol. – 2012. – Vol. 110 (1). – P. 70–72.247. Schiffrin E.
L. The immune system: role in hypertension // Can. J. Cardiol. –2013. – Vol. 29 (5). – P. 543–548.248. Schiffrin E. L. Immune mechanisms in hypertension and vascular injury //Clin. Sci. (Lond). – 2014. – Vol. 126 (4). – P. 267–274.249. Schwarz S., Obst A., Schwahn C. et al. Menopausal hormone therapy doesnot play a major role in left ventricular hypertrophy // Maturitas. – 2010.
–Vol. 66 (2). – P. 212–218.250. Sciacqua A., Perticone M., Miceli S. et al. Endothelial dysfunction andnonalcoholic liver steatosis in hypertensive patients // Nutr. Metab. Cardiovasc.Dis. – 2011. – Vol. 21(7). – P. 485-491.251. Scott M, Grundy MD, Becker D et al. National Cholesterol EducationProgram (NCEP) Expert Panel on Detection, Evaluation, and Treatment ofHight Blood Cholesterolin Adults (Adult Treatment Panel III). Third Report ofthe National Cholesterol Education Program (NCEP) expert panel on detection,evaluation, and treatment of hight blood cholesterol in adults (Adult TreatmentPanel III) final report.
Circulation. - 2002. Vol. – 106 – P. 3143-3421.252. Seufert J. Leptin effects on pancreatic b-cell gene expression and function //Diabetes. – 2004. – Vol. 53 (1). – P. 152–158.142253. Sherif K., Kushner H., Falkner B. E. Sex hormone-binding globulin andinsulin-resistance in African-American women // Metabolism. – 1998. –Vol. 47. – P. 70–74.254. Shimada K., Miyazaki T., Daida H. Adiponectin and atherosclerotic disease //Clinica Chimica Acta. – 2004.
– Vol. 344. P. 1–12.255. Shin D., Seung K. B., Yoon H. E. et al. Microalbuminuria is independantlyassociated with arterial stiffness and vascular inflammation bat not with carotidintima-media thickness in patients with newly diagnosed type 2 diabetes oressential hypertension // J. Korean Med.
Sci. – 2013. – Vol. 28. – P. 252–260.256. Sjoberg L., Kaaja R., Tuomilehto J. Эпидемиология артериальнойгипертонии в период менопаузы // Обзоры клинической кардиологии. –2005. – № 3. – С. 5–16.257. Sierra-Jonson J. Romero-Corral A., Lopez-Jimenez F. et al. Relation ofincreaced leptin concentrations to hhistory of myocardial infarction and strokein the Unated States population // Am. J. Cardiol. – 2007. – Vol. 100. – P. 234–239.258.
Silha J. V., Krsek M., Skrha J. V. et al. Plasma resistin, adiponectin and leptinlevels in lean and obese subjects: correlations with insulin resistance // Eur. J.Endocrinol. – 2003. – Vol. 149. – P. 331–335.259. Silswal N., Singh A. K., Aruna B. et al. Human resistin stimulates the proinflammatory cytokines TNF-a and IL-12 in macrophages by NF-kappaBdependent pathway // Biochem. and Biophys. Res. Commun. – 2005. –Vol. 334. – P. 1092–1101.260. Simmons R.
K., Alberti K. G. M. M., Gale E. A. M. et al. Metabolicsyndrome: useLful consept or clinical tool? Report of a WHO expertconsultation // Diabetologia. – 2010. – Vol. 53 (4). – Р. 600–605.261. Simpkin J. C., Yellon D. M., Davidson S. M. et al. Apelin-13 and apelin-36exhibit direct cardioprotective activity against ischemia-reperfusion injury //Basic Res. in Cardiol. – 2007. – Vol. 102. – P. 518–528.143262. Singh A. K., Kari J. A.
Metabolic syndrome and chronic kidney disease //Curr. Opin. Nephrol. Hypertens. – 2013. – Vol. 22 (2). – P. 198–203.263. Singh P., Hoffmann M., Wolk R. et al. K. Leptin induces C-reactive proteinexpression in vascular endothelial cells // Arteriosclerosis, Thrombosis, andVascular Biology. – 2007. – Vol. 27. – P. 302–307.264. Song S. N., Hardisty C. A.Diagnosing metabolic syndrome in type 2diabetes: Does it matter? // J. Med. – 2008. – Vol. 101 (6). – Р. 487–491.265.
Spenser C. P, Godsland I. F., Stevenson C. Is there a menopause metabolicsyndrome? // Gynecol. Endocrinol. – 1997. – Vol. 11. – P. 341–345.266. Staab C. A., Maser E. 11beta-Hydroxysteroid dehydrogenase type 1 is animportant regulator at the interface of obesity and inflammation // J. Steroid.Biochem. Mol. Biol. – 2010. – Vol. 119 (1-2).
– P. 56–72.267. Stewart J. A. Jr, Cashatt D. O., Borck A. C. et al. 17beta-estradiol modulationof angiotensin II-stimulated response in cardiac fibroblasts // J. Mol. Cell.Cardiol. – 2006. – Vol. 41 (1) – P. 97–107.268. Sullivan K. E., Black L.
D. The role of cardiac fibroblasts in extracellularmatrix-mediatedsignalingduringnormalandpathologicalcardiacdevelopment // J. Biomech. Eng. – 2013. – Vol. 135 (7). – P. 71001.269. Superko R. Advanced Lipoprotein Testing and Subfractionation AreClinically Useful // Circulation. – 2009. – Vol. 119. – P. 2383-2395.270. Suzuki T., Hirata K., Elkind M.
S. V. et al. Metabolic syndrome, endothelialdysfunction, and risk of cardiovascular events: the northern Manhattan study(NOMAS) // Am. Heart. J. – 2008. – Vol. 156. – P. 405–410.271. Suzuki T., Yu H. P., Hsieh Y. C. et al. Mitogen activated protein kinase(MAPK) mediates non-genomic pathway of estrogen on T cell cytokineproduction following trauma-hemorrhage // Cytokine. – 2008. – Vol. 42. –P. 32–38.272. Suzuki T., Yu H.
P., Hsieh Y. C. et al. Estrogen-mediated activation of nongenomic pathway improves macrophages cytokine production followingtrauma-hemorrhage // J. Cell. Physiol. – 2008. – Vol. 214 (3). – P. 662–672.144273. Szokodi I., Tavi P., Foldes G. et al. Apelin, the novel endogenous ligand ofthe orphan receptor APJ, regulates cardiac contractility // Circulation Research.– 2002. – Vol. 91. – P. 434–440.274. Tsiotra P. C., Tsigos C., Raptis S. A. TNFalpha and leptin inhibit basal andglucose-stimulated insulin secretion and gene transcription in the HIT-T15pancreatic cells // Int. J. Obesity and Related Metabol. Dis. – 2001.
– Vol. 25. –P. 1018–1026.275. Таbur S., Torun A. N., Sabuncu T. et al. Non diabetic metabolic syndromeand obesity do not affect serum paraoxonase and arylesterase activities but doaffect ocsidative stress and inflammation // Eur. J. Endocrinol. – 2010. – Vol.16 (3). – P. 535–541.276. Takahashi M., Takahashi Y., Takahashi K. et al. Chemerin enhances insulinsignaling and potentiates insulin-stimulated glucose uptake in 3T3-L1adipocytes // FEBS Letters.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
